您所在的位置: 首页 --> 导师团队 --> 解云涛

导师基本信息

  • 姓名:解云涛
  • 性别:
  • 民族:汉族
  • 科室:乳腺中心
  • 职称:主任医师 ,教授
  • 专业:肿瘤学 ,肿瘤外科学
  • E-MAIL: zlxyt2@bjmu.edu.cn

学术论文 | 研究方向 | 招生计划

HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers. Cancer Sci ,2017,108(4):671-677

Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients. Clin Cancer Res ,2017,23(20):6113-6119

HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negativebreast cancer. Oncol Lett ,2017;13(5):3793-3798

Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA-negative breast cancers Cancer Sci ,109(1):166-173

Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer. Breast Cancer Res Treat ,2016,158(3):455–462

Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations. Breast Cancer Res Treat ,156(3):441-5

A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Oncotarget ,7(4):5042-52

Incidence of BRCA1 somatic mutations and response to neoadjuvant chemotherapy in Chinese women with triple-negative breast cancer. Gene ,584(1):26-30

TP53 Mutations Are Associated with Higher Rates of Pathologic Complete Response to Anthracycline/Cyclophosphamide-Based Neoadjuvant Chemotherapy in Operable Primary Breast Cancer. Int J Cancer ,138(2):489-96

Association between HER2 status and response to neoadjuvant anthracycline followed by paclitaxel plus carboplatin chemotherapy without trastuzumab in breast cancer. Chin J Cancer Res ,27(6):553-61

A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer. Breast Cancer Res Treat ,154(2):423-34

Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer. PLoS Genet ,11(5):e1005228

Association of PIK3CA Mutation Status Before and After Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer. Clin Cancer Res ,21(19):4365-72

Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer. BMC Cancer ,15:194

Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer. Ann Oncol ,26(3):523-8

RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients. Int J Cancer. ,143(8):1935-1942

Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer. Clin Genet ,94(1):165-169.

Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients. Breast Cancer Res Treat. ,174(3):639-647

Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients. BMC Cancer. ,18(1):662

Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancers. Ann Oncol. ,29(10):2046-2051

Association between HER2 germline mutation A270S and prognosis in patients with primary breast cancer. Cancer Biomark. ,23(2):165-171

Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients. Breast Cancer Res Treat. ,169(1):59-67

Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer. J Cancer Res Clin Oncol. ,Epub ahead of print

研究生招生计划
招生年度 招生专业 学位级别 学位类型 研究方向 选拔方式
2020 肿瘤外科学 博士 专业学位 临床医疗技能训练与研究 申请考核制
2020 肿瘤外科学 硕士 专业学位 临床医疗技能训练与研究 全国统考